Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists

Journal of Medicinal Chemistry

Volumn 52, Issue 13, 2009, Pages 4068-4071

  Guerrini, Remo ^a   Camarda, Valeria ^a   Trapella, Claudio ^a   Caló, Girolamo ^a   Rizzi, Anna ^a   Ruzza, Chiara ^a   Fiorini, Stella ^a   Marzola, Erika ^a   Reinscheid, Rainer K ^b   Regoli, Domenico ^a   Salvadori, Severo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CALCIUM; GLYCINE; ISOLEUCINE; LEUCINE; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR ANTAGONIST; OPIATE ANTAGONIST; THREONINE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN;

CALCIUM; CELL LINE; DRUG DISCOVERY; HUMANS; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67649992834     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm900604g     Document Type: Article

References (26)

1. Xu, Y. L.; Reinscheid, R. K.; Huitron-Resendiz, S.; Clark, S. D.; Wang, Z.; Lin, S. H.; Brucher, F. A.; Zeng, J.; Ly, N. K.; Henriksen, S. J.; de Lecea, L.; Civelli, O. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004, 43, 487-497.
2. Rizzi, A.; Vergura, R.; Marzola, G.; Ruzza, C.; Guerrini, R.; Salvadori, S.; Regoli, D.; Calo, G. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br. J. Pharmacol. 2008, 154, 471-479.
3. Leonard, S. K.; Dwyer, J. M.; Sukoff Rizzo, S. J.; Platt, B.; Logue, S. F.; Neal, S. J.; Malberg, J. E.; Beyer, C. E.; Schechter, L. E.; Rosenzweig-Lipson, S.; Ring, R. H. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology (Berlin) 2008, 197, 601-611.
4. Vitale, G.; Filaferro, M.; Ruggieri, V.; Pennella, S.; Frigeri, C.; Rizzi, A.; Guerrini, R.; Calo, G. Anxiolytic-like effect of neuropeptide S in the rat defensive burying. Peptides 2008, 29, 2286-2291.
5. Jungling, K.; Seidenbecher, T.; Sosulina, L.; Lesting, J.; Sangha, S.; Clark, S. D.; Okamura, N.; Duangdao, D. M.; Xu, Y. L.; Reinscheid, R. K.; Pape, H. C. Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 2008, 59, 298-310.
6. Smith, K. L.; Patterson, M.; Dhillo, W. S.; Patel, S. R.; Semjonous, N. M.; Gardiner, J. V.; Ghatei, M. A.; Bloom, S. R. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 2006, 147, 3510-3518.
7. Beck, B.; Fernette, B.; Stricker-Krongrad, A. Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochem. Biophys. Res. Commun. 2005, 332, 859-865.
8. Cline, M. A.; Godlove, D. C.; Nandar, W.; Bowden, C. N.; Prall, B. C. Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus). Comp. Biochem. Physiol., Part A: Mol. Integr. Physiol. 2007, 148, 657-663.
9. Meis, S.; Bergado-Acosta, J. R.; Yanagawa, Y.; Obata, K.; Stork, O.; Munsch, T. Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS One 2008, 3, e2695.
10. Badia-Elder, N. E.; Henderson, A. N.; Bertholomey, M. L.; Dodge, N. C.; Stewart, R. B. The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats. Alcohol.: Clin. Exp. Res. 2008, 32, 1380-1387.
11. Li, W.; Gao, Y. H.; Chang, M.; Peng, Y. L.; Yao, J.; Han, R. W.; Wang, R. Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice. Peptides 2009, 30, 234-240.
12. Paneda, C.; Huitron-Resendiz, S.; Frago, L. M.; Chowen, J. A.; Picetti, R.; de Lecea, L.; Roberts, A. J. Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice. J. Neurosci. 2009, 29, 4155-4161.
13. Cannella, N.; Economidou, D.; Kallupi, M.; Stopponi, S.; Heilig, M.; Massi, M.; Ciccocioppo, R. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology, in press.
14. Bernier, V.; Stocco, R.; Bogusky, M. J.; Joyce, J. G.; Parachoniak, C.; Grenier, K.; Arget, M.; Mathieu, M. C.; O'Neill, G. P.; Slipetz, D.; Crackower, M. A.; Tan, C. M.; Therien, A. G. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. J. Biol. Chem. 2006, 281, 24704-24712.
15. Reinscheid, R. K.; Xu, Y. L.; Okamura, N.; Zeng, J.; Chung, S.; Pai, R.; Wang, Z.; Civelli, O. Pharmacological characterization of human and murine neuropeptide S receptor variants. J. Pharmacol. Exp. Ther. 2005, 315, 1338-1345.
16. Roth, A. L.; Marzola, E.; Rizzi, A.; Arduin, M.; Trapella, C.; Corti, C.; Vergura, R.; Martinelli, P.; Salvadori, S.; Regoli, D.; Corsi, M.; Cavanni, P.; Calo, G.; Guerrini, R. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. J. Biol. Chem. 2006, 281, 20809-20816.
17. Tancredi, T.; Guerrini, R.; Marzola, E.; Trapella, C.; Calo, G.; Regoli, D.; Reinscheid, R. K.; Camarda, V.; Salvadori, S.; Temussi, P. A. Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor. J. Med. Chem. 2007, 50, 4501-4508.
18. Camarda, V.; Trapella, C.; Calo, G.; Guerrini, R.; Rizzi, A.; Ruzza, C.; Fiorini, S.; Marzola, E.; Reinscheid, R. K.; Regoli, D.; Salvadori, S. Synthesis and biological activity of human neuropeptide S analogues modified in position 2. J. Med. Chem. 2008, 51, 655-658.
19. Camarda, V.; Trapella, C.; Calo, G.; Guerrini, R.; Rizzi, A.; Ruzza, C.; Fiorini, S.; Marzola, E.; Reinscheid, R. K.; Regoli, D.; Salvadori, S. Structure activity study at position 3 and 4 of human neuropeptide S. Bioorg. Med. Chem. 2008, 16, 8841-8845.
20. Guerrini, R.; Camarda, V.; Trapella, C.; Calo, G.; Rizzi, A.; Ruzza, C.; Fiorini, S.; Marzola, E.; Reinscheid, R.; Regoli, D.; Salvadori, S. Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure NPS receptor antagonists. J. Med. Chem. 2009, 52, 524-529.
21. Camarda, V.; Rizzi, A.; Ruzza, C.; Zucchini, S.; Marzola, G.; Marzola, E.; Guerrini, R.; Salvadori, S.; Reinscheid, R. K.; Regoli, D.; Calo, G. In vitro and in vivo pharmacological characterization of the neuropeptides S receptor antagonist [D-Cys(tBu)5]NPS. J. Pharmacol. Exp. Ther. 2009, 328, 549-555.
22. Kenakin, T. A Pharmacology Primer, 2nd ed.; Elsevier Academic Press: San Diego, CA, 2006.
23. Coward, P.; Chan, S. D.; Wada, H. G.; Humphries, G. M.; Conklin, B. R. Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors. Anal. Biochem. 1999, 270, 242-248.
24. qi5. Naunyn-Schmiedeberg's Arch. Pharmacol. 2009, 379, 599-607.
25. Okamura, N.; Habay, S. A.; Zeng, J.; Chamberlin, A. R.; Reinscheid, R. K. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. J. Pharmacol. Exp. Ther. 2008, 325, 893-901.
26. Li, W.; Chang, M.; Peng, Y. L.; Gao, Y. H.; Zhang, J. N.; Han, R. W.; Wang, R. Neuropeptide S produces antinociceptive effect at the supraspinal level in mice. Regul. Pept., in press.